ArticleThe oncologist2023

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.

Xiao-Li Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.